PRNP and prion disease: However, further developments in this method, primarily through the use of recombinant PrP produced in Escherichia coli and chemically defined substrates devoid of brain homogenate, led to an important milestone in prion disease research: the spontaneous generation of a highly infectious recombinant prion in PMCA using minimal components [31].